Investigators posit that endogenous estrogen may have a protective effect against schizophrenia.
Asim Shah, MD, and Syed Z. Iqbal, MD, discuss the use of paliperidone to treat adult patients with schizophrenia.
Researchers weigh in on the use of placebo-controlled trials in schizophrenia.
Investigators found data that showed a ghrelinergic signaling mechanism may be responsible for increased appetite in patients with MDD.
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.